AAO-HNS Thyroid Cancer Tumor Board

Monday, September 30, 2024

2:30 PM – 3:30 PM EDT

Location: MBCC, 209

CME/MOC Credit: 1

Disclosure(s):

Marika D. Russell, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Gregory W. Randolph, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Joseph Scharpf, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: The proposed session is an AAO-HNS Thyroid Cancer Tumor Board. The moderators will present cases which highlight challenges and advances in thyroid cancer management. The expert panel will be asked to share their experience and strategies for the work-up and management of varied clinical entities, including low-risk differentiated thyroid cancer, advanced thyroid cancer, oncocytic carcinoma and medullary thyroid carcinoma.

This case-based tumor board session will address state-of-the-art contemporary management of thyroid cancer from diagnosis to preoperative evaluation and surgical management. The diagnostic and prognostic relevance of molecular analysis will be discussed, especially as it relates to extent of surgery. Use of radiofrequency ablation to treat thyroid cancer will be deliberated. The complex task of surgically managing the invaded recurrent laryngeal nerve will be addressed. Finally, discussion will cover the use of neoadjuvant targeted therapy in management of advanced thyroid cancer, a promising new treatment paradigm.

Learning Objectives:

Appreciate the diagnostic utility and prognostic significance of mutational analysis in the diagnosis and management of thyroid cancer, including its application to initiation of neoadjuvant targeted therapy.
Discuss the emerging use of radiofrequency ablation in the treatment of thyroid cancer.
Develop an appreciation for thoughtful and strategic management of the invaded recurrent laryngeal nerve using state-of-the-art nerve monitoring techniques.

Moderator(s)

Marika D. Russell, MD

Assistant Professor, Otolaryngology - Head and Neck Surgery
Harvard Medical School/Mass Eye and Ear
Boston, MA, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
GR

Gregory W. Randolph, MD

Professor
Massachusetts Eye and Ear Infirmary Harvard
Boston, MA, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Panelist(s)

JS

Joseph Scharpf, MD

Professor
Cleveland Clinic Foundation
Chagrin Falls, OH, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Elizabeth E. Cottrill, MD

Associate Professor, Otolaryngology H&N Surgery, Program Director
Thomas Jefferson University Hospital
Philadelphia, PA, United States

Disclosure information not submitted.
Erin J. Buczek, MD

Associate Professor
University of Kansas
Kansas City, KS, United States

Disclosure information not submitted.